Ankita Mitra

NYU Langone Health — United States

Medicine · Health Sciences

6h-index123citations47works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(25), Immune Cell Function and Interaction(25), CAR-T cell therapy research(23), Immunotherapy and Immune Responses(5), T-cell and B-cell Immunology(3)

Publications47 total

Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
2025Open Access
Supplementary Tables 1-8 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
2025Open Access
CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
2025Open Access
Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
2025Open Access
Supplementary Figures 1-7 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
2025Open Access
Abstract 5922: B cell subtype is a predictive and pharmacodynamic biomarkers for combination therapy in stage III-IV melanoma: a simon phase II trial
Cancer Research·2025
Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Data from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Supplementary Tables 1-8 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Supplementary Tables 1-8 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Supplementary Figures 1-7 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Supplementary Figures 1-7 from A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
2024Open Access
Predictive and pharmacodynamic biomarkers for combination therapy in stage III-IV melanoma: A Simon phase II trial (NCT03999749).
Journal of Clinical Oncology·2024· 1 cited
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Biology·2024· 42 citedOpen Access
Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors
International review of cell and molecular biology·2024· 2 cited
page 1 of 3Next →

Frequent Co-authors

Jeffrey S. Weber(33), David Woods(32), Tomoaki Muramatsu(31), Diana Kimono(31), Amrutesh S. Puranik(31), Brian Thompson(30), Ann Strange(30), Carol M. Amato(30), Melinda Vassallo(29), Igor Dolgalev(29), Jonathan Hester-McCullough(29), Sudarvili Shanthalingam(5), Barbara A. Osborne(4), Mine Canakci(3), Khushboo Singh(3), S. Thayumanavan(3), Rebecca Lawlor(3), Oyuntuya Munkhbat(2), Mallory R. Gordon(2), Heather L. Sherman(2)